Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

South African studies suggest Omicron has higher 'asymptomatic carriage'

Published 11/01/2022, 09:26
Updated 11/01/2022, 09:30
© Reuters. A woman wearing a protective face mask against the coronavirus disease (COVID-19) and a plastic bag on her head to protect from the rain looks on, as the new Omicron coronavirus variant spreads, at Tsomo, a town in the Eastern Cape province of South Afric

© Reuters. A woman wearing a protective face mask against the coronavirus disease (COVID-19) and a plastic bag on her head to protect from the rain looks on, as the new Omicron coronavirus variant spreads, at Tsomo, a town in the Eastern Cape province of South Afric

JOHANNESBURG (Reuters) - Preliminary findings from two South African clinical trials suggest the Omicron coronavirus variant has a much higher rate of "asymptomatic carriage" than earlier variants, which could explain why it has spread so rapidly across the globe.

The studies - one of which was carried out when Omicron infections were surging in South Africa last month and another which resampled participants around the same time - found a far greater number of people tested positive for the coronavirus but were not showing symptoms compared to previous trials.

In the Ubuntu study evaluating the efficacy of Moderna (NASDAQ:MRNA)'s COVID-19 vaccine in people living with HIV, 31% of 230 participants undergoing screening tested positive, with all 56 samples available for sequencing analysis verified to be Omicron.

"This is in stark contrast to the positivity rate pre-Omicron, which ranged from less than 1% to 2.4%," the researchers said in a statement.

In a subgroup of the Sisonke trial evaluating the efficacy of Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine, the mean asymptomatic carriage rate rose to 16% during the Omicron period from 2.6% during the Beta and Delta outbreaks.

"The Sisonke study included 577 subjects previously vaccinated, ... with results suggesting a high carriage rate even in those known to be vaccinated," the researchers said.

© Reuters. A woman wearing a protective face mask against the coronavirus disease (COVID-19) and a plastic bag on her head to protect from the rain looks on, as the new Omicron coronavirus variant spreads, at Tsomo, a town in the Eastern Cape province of South Africa, December 2, 2021. REUTERS/Siphiwe Sibeko/Files

They added that the "higher asymptomatic carriage rate is likely a major factor in the rapid and widespread dissemination of the variant, even among populations with high prior rates of coronavirus infection".

South Africa experienced a surge in COVID-19 infections from late November, around the time its scientists alerted the world to Omicron. But new cases have since fallen back and early indications are that the wave has been marked by less serious disease than earlier ones.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.